Sign in

CIK 0001756262

  • Large accelerated filer

TransMedics Group, Inc.

Sign in to watch
Ticker
TMDX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
MA
Entity type
Operating
Phone
+1 978-552-0900
Business address
200 MINUTEMAN ROAD, ANDOVER, MA, 01810
Open-market buys, last 90 days
$109,058
in 1 filing
Open-market sales, last 90 days
$385,464
in 1 filing

Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. TOBIN JAMES R −$385K Director sold 58% of stake
  2. Weill David +$109K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-23 Khayal Tamer I Chief Commercial Officer Exercise or conversion +32,179 $16.00 $515K 46,554
2023-02-23 Khayal Tamer I Chief Commercial Officer Exercise or conversion +3,751 $16.14 $61K 50,305
2023-02-23 Khayal Tamer I Chief Commercial Officer Sale −6,319 $70.18 $443K 43,986
2023-02-23 Khayal Tamer I Chief Commercial Officer Sale −1,763 $71.46 $126K 42,223
2023-02-23 Khayal Tamer I Chief Commercial Officer Sale −6,218 $72.02 $448K 36,005
2023-02-23 Khayal Tamer I Chief Commercial Officer Sale −777 $73.55 $57K 35,228
2023-02-23 Khayal Tamer I Chief Commercial Officer Sale −853 $74.67 $64K 34,375
2023-02-23 Khayal Tamer I Chief Commercial Officer Sale −20,000 $75.15 $1.5M 14,375
2023-02-23 Khayal Tamer I Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) −32,179 8,036
2023-02-23 Khayal Tamer I Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) −3,751 46,249
2023-02-20 Provost Miriam VP, Global Regulatory Affairs Grant or award +5,685 20,839
2023-02-20 Provost Miriam VP, Global Regulatory Affairs Grant or award · Stock Option (Right to Buy) +8,705 8,705
2023-02-20 Khayal Tamer I Chief Commercial Officer Grant or award +13,075 14,375
2023-02-20 Khayal Tamer I Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +20,022 20,022
2023-02-20 DAMME LAURA VP, Clinical Affairs Grant or award +5,685 5,685
2023-02-20 DAMME LAURA VP, Clinical Affairs Grant or award · Stock Option (Right to Buy) +8,705 8,705
2023-02-20 Corcoran Nicholas Grant or award +12,886 12,886
2023-02-20 Corcoran Nicholas Grant or award · Stock Option (Right to Buy) +19,732 19,732
2023-02-20 Hassanein Waleed H President & CEO Grant or award +37,332 426,444
2023-02-20 Hassanein Waleed H President & CEO Grant or award · Stock Option (Right to Buy) +57,165 57,165

Page 28 of 38 · 744 trades